Notably, significant downregulation of CD28 with its overall cytokine production profile has been associated with poorer clinical outcomes in IPF subjects, consistent with findings in other patient cohorts with chronic immunologic conditions [67,68]. This evidence concerns the gene CD28 and idiopathic pulmonary fibrosis.